(Q37580524)

21 August 2017

1 reference

title

Potential of immunomodulatory host defense peptides as novel anti-infectives (English)

1 reference

21 August 2017

4

Robert E W Hancock

1 reference

21 August 2017

Donna M Easton

1

1 reference

PubMed ID

19683819

21 August 2017

Anastasia Nijnik

series ordinal

2

1 reference

PubMed ID

19683819

21 August 2017

Matthew L Mayer

series ordinal

3

1 reference

21 August 2017

14 August 2009

1 reference

21 August 2017

Trends in Biotechnology

1 reference

21 August 2017

27

1 reference

21 August 2017

10

1 reference

21 August 2017

582-590

1 reference

Histatins: antimicrobial peptides with therapeutic potential

21 August 2017

1 reference

12 December 2020

Anti-cytokine therapeutics and infections

1 reference

12 December 2020

The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells

1 reference

12 December 2020

Adverse consequences of immunostimulation

1 reference

12 December 2020

The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.

1 reference

12 December 2020

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

1 reference

12 December 2020

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

1 reference

12 December 2020

Targeting signal transduction as a strategy to treat inflammatory diseases.

1 reference

12 December 2020

Staphylococcus aureus evasion of innate antimicrobial defense

1 reference

12 December 2020

Dendritic cell immunotherapy: mapping the way.

1 reference

12 December 2020

Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity

1 reference

12 December 2020

Novel anti-infectives: is host defence the answer?

1 reference

12 December 2020

A re-evaluation of the role of host defence peptides in mammalian immunity.

1 reference

12 December 2020

[Glutoxim in the complex treatment of tuberculosis]

1 reference

12 December 2020

Host defense peptides in wound healing.

1 reference

12 December 2020

Chemokines and their receptors: drug targets in immunity and inflammation

1 reference

12 December 2020

A network view of disease and compound screening

1 reference

12 December 2020

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

1 reference

12 December 2020

Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils

1 reference

12 December 2020

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

12 December 2020

The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.

1 reference

12 December 2020

Immunomodulatory effect of glutoxim on some activities of isolated human neutrophils and in whole blood

1 reference

12 December 2020

Immunotherapy: past, present and future

1 reference

12 December 2020

Identification of novel antibacterial peptides by chemoinformatics and machine learning

1 reference

12 December 2020

Cathelicidins, multifunctional peptides of the innate immunity

1 reference

12 December 2020

Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock

1 reference

12 December 2020

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

12 December 2020

Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

1 reference

12 December 2020

Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37

1 reference

12 December 2020

Malignancy and biologic therapy in rheumatoid arthritis

1 reference

12 December 2020

Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells.

1 reference

12 December 2020

1 reference

12 December 2020

The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands.

1 reference

12 December 2020

Targeting the innate immune response with improved vaccine adjuvants

1 reference

12 December 2020

Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide

1 reference

12 December 2020

Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway.

1 reference

12 December 2020

The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization

1 reference

12 December 2020

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

1 reference

12 December 2020

Social and environmental risk factors in the emergence of infectious diseases

1 reference

12 December 2020

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

1 reference

12 December 2020

Neutrophil secretion products pave the way for inflammatory monocytes

1 reference

12 December 2020

Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities

1 reference

12 December 2020

InnateDB: facilitating systems-level analyses of the mammalian innate immune response.

1 reference

12 December 2020

RDP-58 (SangStat Medical).

1 reference

12 December 2020

Treatment of sepsis: current status of clinical immunotherapy.

1 reference

12 December 2020

Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs

1 reference

12 December 2020

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

1 reference

12 December 2020

A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release

1 reference

12 December 2020

The relationship between peptide structure and antibacterial activity

1 reference

12 December 2020

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

12 December 2020

Immunomodulatory activities of small host defense peptides

1 reference

12 December 2020

Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells

1 reference

12 December 2020

Complexities of targeting innate immunity to treat infection.

1 reference

12 December 2020

Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors

1 reference

12 December 2020

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

1 reference

12 December 2020

Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues

1 reference

12 December 2020

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity

1 reference

12 December 2020

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock

1 reference

12 December 2020

Impact of LL-37 on anti-infective immunity.

1 reference

12 December 2020

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

1 reference

12 December 2020

The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.

1 reference

12 December 2020

Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells

1 reference

12 December 2020

Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer

1 reference

12 December 2020

RDP58 is a novel and potentially effective oral therapy for ulcerative colitis.

1 reference

12 December 2020

The design, synthesis and application of stereochemical and directional peptide isomers: a critical review

1 reference

12 December 2020

Defensins and cathelicidins in gastrointestinal infections

1 reference

12 December 2020

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

1 reference

12 December 2020

An anti-infective peptide that selectively modulates the innate immune response.

1 reference

12 December 2020

Strategies to link innate and adaptive immunity when designing vaccine adjuvants

1 reference

12 December 2020

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.

1 reference

12 December 2020

From Pasteur to genomics: progress and challenges in infectious diseases.

1 reference

12 December 2020

Evolution of primate theta-defensins: a serpentine path to a sweet tooth

1 reference

12 December 2020

Synthetic oligopeptides related to the [beta]-subunit of human chorionic gonadotropin attenuate inflammation and liver damage after (trauma) hemorrhagic shock and resuscitation

1 reference

12 December 2020

In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37.

1 reference

12 December 2020

Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer

1 reference

12 December 2020

Defensins: antimicrobial peptides of innate immunity

1 reference

12 December 2020

IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses

1 reference

12 December 2020

Mechanisms of endotoxin neutralization by synthetic cationic compounds

1 reference

12 December 2020

10.1016/J.TIBTECH.2009.07.004

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19683819